Support DPI drug development programs by (1) developing and validating sensitive and bioanalytical methods to quantify concentrations of novel biologics; (2) developing assays for measurement of…

Active Awarded Last action

Contract number
HHSN271201800008I
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 95% complete
IDV ceiling
$3,912,150.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $3.9 million contract supports NCATS' drug development programs by (1) developing and validating sensitive bioanalytical methods to quantify concentrations of novel biologics, (2) developing assays to measure anti-drug antibodies, and (3) providing bioanalytical support for drug concentration and anti-drug antibody measurement. The contract does not have any set-aside provisions and is a multiple award vehicle with a period of performance through March 2027. Through this indefinite delivery contract and associated task orders, Sri International will leverage its expertise in biomedical sciences, data analytics, and laboratory services to support NCATS' drug development initiatives. The contract aims to enhance the agency's capabilities in biologics characterization and immunogenicity assessment to further progress novel therapeutic candidates.

Description

As the agency reported it.

Support DPI drug development programs by (1) developing and validating sensitive and bioanalytical methods to quantify concentrations of novel biologics; (2) developing assays for measurement of anti-drug antibodies; and (3) providing bioanalytical support for drug concentration and antidrug antibody measurement.

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 · CRO support for ncats bioanalytical method development for biologics $0
Original award $5,000

Quick answers

Who was awarded contract HHSN271201800008I?

HHSN271201800008I was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on March 26, 2018.

How much is contract HHSN271201800008I worth?

HHSN271201800008I's own ceiling is $3,912,150.

Which agency awarded contract HHSN271201800008I?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201800008I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract HHSN271201800008I?

HHSN271201800008I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201800008I part of a contract vehicle?

Yes. HHSN271201800008I is part of CRO Support for NCATS Bioanalytical Method Development.

Was contract HHSN271201800008I competed?

The extent of competition for HHSN271201800008I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login